Glucose News and Research

RSS

Echo Therapeutics declares reverse split of issued and outstanding common stock

Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013.

7 Jun 2013

Echo Therapeutics to evaluate safety, efficacy of Symphony CGM System in hospital setting

Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe.

5 Jun 2013

Research: 8% drop in BMI lowers risk factor for type 2 diabetes in obese teenagers

Obese teenagers who reduced their body mass index (BMI) by 8 percent or more had improvements in insulin sensitivity, an important metabolic factor related to the later development of type 2 diabetes. The teens followed a family-based, lifestyle-modification weight loss program that offers the potential to become a broader model.

5 Jun 2013

Weight-loss surgery may improve metabolic risk factors in obese patients: Study

Among mild to moderately obese patients with type 2 diabetes, adding gastric bypass surgery to lifestyle and medical management was associated with a greater likelihood of improved levels of metabolic risk factors such as blood glucose, LDL-cholesterol and systolic blood pressure, according to a study in the June 5 issue of JAMA.

5 Jun 2013

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

Integrity Applications, Inc. announced today that it has received CE Mark approval for its GlucoTrack DF-F non-invasive blood glucose measurement device.

4 Jun 2013

Baylor Endocrine Center seeks volunteers to compare long-term benefits and risks of diabetes drugs

Baylor Endocrine Center is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The project is called the GRADE: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study.

4 Jun 2013

New tool enables doctors to monitor infections, inflammation and scarring in lungs

Intensive care patients who are on breathing support could be helped by a new tool to enable doctors to see inside their lungs to check for and monitor infections, inflammation and scarring.

4 Jun 2013

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

The American Academy of Sleep Medicine is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician. The recommendation comes as the group of international clinicians and researchers meets in Baltimore for SLEEP 2013, the foremost gathering of sleep experts annually.

4 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

Patients with type 2 diabetes have altered gut microbiota

Intestinal bacteria may have a greater influence on us than was previously thought. In a study published in the prestigious journal Nature on 29 May, researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden and Chalmers University of Technology, Sweden, show that patients with type 2 diabetes have an altered gut microbiota.

3 Jun 2013

UB researchers are developing a network of wireless body sensors

The military has for decades used sonar for underwater communication. Now, researchers at the University at Buffalo are developing a miniaturized version of the same technology to be applied inside the human body to treat diseases such as diabetes and heart failure in real time.

1 Jun 2013

International researchers find how brain cancer cells survive and drive tumor growth

An international team of researchers - led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine - has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly by altering the splicing of genes that control cellular metabolism.

1 Jun 2013

Popular artificial sweetener can modify how the body handles sugar, find researchers

Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar.

30 May 2013

New Smartphone app helps maintain accurate records to manage diabetes

Vital improvements can be made to patients diabetes control, by ensuring a recent blood glucose history is available to their Specialist Nurse. Traditionally patients have recorded their results in a paper logbook but now the new app from GlucoMen is a fantastic alternative using Smartphone technology to ensure a complete and accurate record.

28 May 2013

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.

28 May 2013

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes.

28 May 2013

New evidence shows intensive insulin therapy does not provide substantial benefits

High blood glucose is associated with poor outcomes in hospitalized patients, and use of intensive insulin therapy (IIT) to control hyperglycemia is a common practice in hospitals. But the recent evidence does not show a consistent benefit and even shows harms associated with the use of IIT, according to the American College of Physicians' (ACP) Clinical Guidelines Committee in a new evidence-based paper published today online in the American Journal of Medical Quality.

24 May 2013

Lifestyle behaviors can lower risk of kidney failure in people with CKD

Lifestyle behaviors like working out and improving nutrition can lower the risk of kidney failure in people with chronic kidney disease, according to new research from the University of Alabama at Birmingham.

24 May 2013

Cinnamon compounds show some promise in the effort to fight Alzheimer's disease

Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of -- or warding off -- the effects of Alzheimer's disease.

24 May 2013

Echo Therapeutics unveils Symphony CGM System

Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the successful unveiling and demonstration of its Symphony CGM System during a live webcast following yesterday's annual stockholders meeting.

24 May 2013

Glucose News and Research

Echo Therapeutics declares reverse split of issued and outstanding common stock

Echo Therapeutics to evaluate safety, efficacy of Symphony CGM System in hospital setting

Research: 8% drop in BMI lowers risk factor for type 2 diabetes in obese teenagers

Weight-loss surgery may improve metabolic risk factors in obese patients: Study

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

Baylor Endocrine Center seeks volunteers to compare long-term benefits and risks of diabetes drugs

New tool enables doctors to monitor infections, inflammation and scarring in lungs

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Patients with type 2 diabetes have altered gut microbiota

UB researchers are developing a network of wireless body sensors

International researchers find how brain cancer cells survive and drive tumor growth

Popular artificial sweetener can modify how the body handles sugar, find researchers

New Smartphone app helps maintain accurate records to manage diabetes

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

New evidence shows intensive insulin therapy does not provide substantial benefits

Lifestyle behaviors can lower risk of kidney failure in people with CKD

Cinnamon compounds show some promise in the effort to fight Alzheimer's disease

Echo Therapeutics unveils Symphony CGM System

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News